# Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis

> **NCT01160081** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 3658 (actual)

## Conditions studied

- Viral Hepatitis Vaccines
- Hepatitis A
- Cytomegalovirus
- Varicella-Zoster Virus
- Bordetella Pertussis Infection
- Herpes Simplex (1 and 2)

## Interventions

- **OTHER:** Serum sample

## Key facts

- **NCT ID:** NCT01160081
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 3658 (ACTUAL)
- **Last updated:** 2011-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160081, "Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01160081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*